News

The latest happenings in the clinical trials industry from the past month, all in one place.

FDA has an official new leader, following a Senate vote to confirm Stephen Hahn as the agency’s next commissioner.

David Arthur, CEO of Salarius, discusses how companies like Salarius are incorporating endpoints into early-stage clinical trials that could offer a glimpse into efficacy.

Doug Manion, CEO of Kleo, explains how platform technology essentially involves the engineering of antibodies and biologics using linear process chemistry to enhance drug effectiveness.

CISCRP – in partnership with 10 leading pharmaceutical companies and clinical research service providers – has launched a new consortium that will focus energy and resources on community-based education to improve clinical trial diversity.

How sharing patient data drives trial engagement and honors patient contributions to the research process.

Centralized monitoring offers sponsors and CROs the program-wide oversight they need to successfully develop the medications of the future, says CluePoints CEO, Francois Torche.

Yoong Kai Shen and Joanne Yeoh, both of Clinical Research Malaysia, analyze the pre- and post- workshop assessment score for GCP workshops conducted since 16 March 2017.

Do users actually want to use Excel? Explore the different viewpoints behind choosing SaaS or Excel.